Viseon Funding & Investors
Viseon is a privately held medical device company committed to developing proprietary technology for use in Minimally Invasive Spine Surgery (MISS) procedures. Viseon has progressed rapidly over the past 6-months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive spine surgery procedures. In addition to rapid product development of its initial products, Viseon has assembled a world-class Scientific Advisory Board of leading MISS physicians, amassed 13 patents to solidify its intellectual property platform, and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon. Viseon was founded in early 2017 as a spin-out from Rebound Therapeutics Corporation.
viseon-spine.comTotal Amount Raised: $27,200,000
Viseon Funding Rounds
Series B
$18,000,000
Series B Investors
InvusHBM-MedFocusWexford CapitalSeries A
$5,000,000
Series A Investors
InvusHBM-MedFocusWexford CapitalPost Ipo Equity
$4,200,000